Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06351878 · ClinicalTrials.gov registry record
TipTraQ Home Sleep Test Validation Study, Duke
A clinical trial of Obstructive Sleep Apnea, sponsored by PranaQ Pte..
- Completed
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06351878: Completed study of Obstructive Sleep Apnea, sponsored by PranaQ Pte..
NCT06351878 is a study of Obstructive Sleep Apnea that has completed, run by PranaQ Pte.. The registered enrollment target is 200 participants, roughly in line with the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06351878, a study of Obstructive Sleep Apnea, has completed, sponsored by PranaQ Pte..
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
A validation study has been designed to assess the performance of a home sleep test device, TipTraQ, for screening sleep apnea. The study involves participants wearing the TipTraQ device on their fingertip during a traditional sleep test, known as polysomnography (PSG), conducted in a sleep center. The performance of the device will then be evaluated by comparing the results from the TipTraQ system with those from the traditional sleep test.
Primary Outcome
The combined average number of apneas and hypopneas that occur per hour of sleep
Conditions Studied
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-02-28 |
| Est. Completion | 2024-08-23 |
What the finished NCT06351878 record still lists
NCT06351878 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target.
The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 0 interventions.
NCT06351878 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06351878 about?
NCT06351878 is a clinical study titled "TipTraQ Home Sleep Test Validation Study, Duke". A validation study has been designed to assess the performance of a home sleep test device, TipTraQ, for screening sleep apnea. The study involves participants wearing the TipTraQ device on their fingertip during a traditional sleep test, known as polysomnography (PSG), conducted in a sleep center. ...
What is the current status of trial NCT06351878?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2024-02-28. Estimated completion is 2024-08-23.
What conditions does trial NCT06351878 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea.
Who is sponsoring clinical trial NCT06351878?
This trial is sponsored by PranaQ Pte., which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06351878 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06351878's enrollment target sits among peer trials
200 39th of 155 higher than 113 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities
RECRUITING · Phase 1
-
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
RECRUITING
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
RECRUITING · Phase 2
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI